The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
‘Entourage’ effects of N‐palmitoylethanolamide and N‐oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors
Open accessAbstract
Background and purpose: The endocannabinoid N‐arachidonoylethanolamide (anandamide) is co‐synthesized with other N‐acylethanolamides, namely N‐palmitoylethanolamide (PEA) and N‐oleoylethanolamide (OEA), which have been shown to potentiate anandamide responses (so‐called ‘entourage effects’) in non‐vascular tissues. It remains unclear whether such interactions occur in the circulation. Experimental approach: In rat isolated small mesenteric arteries, the effects of PEA and OEA on relaxation to anandamide and tissue contents of the N‐acylethanolamides were examined under myographic conditions. Key results: Anandamide‐induced relaxation was potentiated by pretreatment with PEA (10 μ M) or OEA (1 μ M), or in combination. The potentiation by PEA and OEA was endothelium‐independent and abolished by treatment with capsaicin (10 μ M), which desensitizes the transient receptor potential vanilloid type 1 (TRPV1) receptor system, or by the TRPV1 receptor antagonist, N‐(3‐methoxyphenyl)‐4‐chlorocinnamide (SB366791) (2 μ M). It was also observed at molar ratios of anandamide and PEA (or OEA) similar to those found in mesenteric arteries. PEA and inhibition of anandamide hydrolysis by 3′‐carbamoyl‐biphenyl‐3‐yl‐cyclohexylcarbamate (URB597) (1 μ M) additively potentiated anandamide responses. On the other hand, PEA and OEA also induced vasorelaxation per se (rank order of potency: anandamide>OEA>PEA), but relaxation to the three N‐acylethanolamides displayed different sensitivity to treatment with capsaicin, SB366791 and URB597. For example, relaxations to anandamide and OEA, but not PEA, were attenuated by both capsaicin and SB366791. Conclusion and implications: This study shows that PEA and OEA potentiate relaxant responses to anandamide through TRPV1 receptors in rat small mesenteric arteries. The congeners also induce vasorelaxation per se, suggesting a function for the N‐acylethanolamides in vascular control. British Journal of Pharmacology (2008) 155, 837–846; doi:10.1038/bjp.2008.324; published online 11 August 2008
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The capsaicin receptor: a heat-activated ion channel in the pain pathway
Caterina, M. J., Schumacher, M. A., Tominaga, M., Rosen, T. A., Levine, J. D., & Julius, D. (1997) · Nature · doi:10.1038/39807 · Cited by 9,107
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Guide to receptors and channels (GRAC), 5th edition
Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947
Vanilloid (Capsaicin) Receptors and Mechanisms
Szallasi, A., & Blumberg, P. M. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01403-0 · Cited by 1,903
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Schwartz, J.-C., & Piomelli, D. (1994) · Nature · doi:10.1038/372686a0 · Cited by 1,587
Ji, R.-R., Samad, T. A., Jin, S.-X., Schmoll, R., & Woolf, C. J. (2002) · Neuron · doi:10.1016/s0896-6273(02)00908-x · Cited by 1,238
Fu, J., Gaetani, S., Oveisi, F., Lo Verme, J., Serrano, A., Rodríguez de Fonseca, F., Rosengarth, A., Luecke, H., Di Giacomo, B., Tarzia, G., et al. (2003) · Nature · doi:10.1038/nature01921 · Cited by 1,064
Control of pain initiation by endogenous cannabinoids
Calignano, A., Rana, G. L., Giuffrida, A., & Piomelli, D. (1998) · Nature · doi:10.1038/28393 · Cited by 1,056
Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners
Okamoto, Y., Morishita, J., Tsuboi, K., Tonai, T., & Ueda, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306642200 · Cited by 805
Induction of vanilloid receptor channel activity by protein kinase C
Premkumar, L. S., & Ahern, G. P. (2000) · Nature · doi:10.1038/35050121 · Cited by 802
The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)
Smart, D., Gunthorpe, M. J., Jerman, J. C., Nasir, S., Gray, J., Muir, A. I., Chambers, J. K., Randall, A. D., & Davis, J. B. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703050 · Cited by 775
Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
Deutsch, D. G., & Chin, S. A. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90486-g · Cited by 702
Ben-Shabat, S., Fride, E., Sheskin, T., Tamiri, T., Rhee, M.-H., Vogel, Z., Bisogno, T., De Petrocellis, L., Di Marzo, V., & Mechoulam, R. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00392-6 · Cited by 629
Járai, Z., Wagner, J. A., Varga, K., Lake, K. D., Compton, D. R., Martin, B. R., Zimmer, A. M., Bonner, T. I., Buckley, N. E., Mezey, E., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14136 · Cited by 599
Vellani, V., Mapplebeck, S., Moriondo, A., Davis, J. B., & McNaughton, P. A. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.00813.x · Cited by 488
N-Acylated glycerophospholipids and their derivatives
Schmid, H. H. O., Schmid, P. C., & Natarajan, V. (1990) · Progress in Lipid Research · doi:10.1016/0163-7827(90)90004-5 · Cited by 451
Mechoulam, R., Fride, E., & Di Marzo, V. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00649-9 · Cited by 428
Fegley, D., Gaetani, S., Duranti, A., Tontini, A., Mor, M., Tarzia, G., & Piomelli, D. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078980 · Cited by 427
Biosynthesis, Uptake, and Degradation of Anandamide and Palmitoylethanolamide in Leukocytes
Bisogno, T., Maurelli, S., Melck, D., De Petrocellis, L., & Di Marzo, V. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3315 · Cited by 369
A Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals
Wei, B. Q., Mikkelsen, T. S., McKinney, M. K., Lander, E. S., & Cravatt, B. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606646200 · Cited by 363
Structural Requirements for Binding of Anandamide-Type Compounds to the Brain Cannabinoid Receptor
Sheskin, T., Hanuš, L., Slager, J., Vogel, Z., & Mechoulam, R. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960752x · Cited by 275
Gunthorpe, M. J., Rami, H. K., Jerman, J. C., Smart, D., Gill, C. H., Soffin, E. M., Luis Hannan, S., Lappin, S. C., Egerton, J., Smith, G. D., et al. (2004) · Neuropharmacology · doi:10.1016/s0028-3908(03)00305-8 · Cited by 274
Activation of TRPV1 by the Satiety Factor Oleoylethanolamide
Ahern, G. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305051200 · Cited by 257
The Palmitoylethanolamide and Oleamide Enigmas: Are These Two Fatty Acid Amides Cannabimimetic?
Lambert, D. M., & Di Marzo, V. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220401153732 · Cited by 243
Ross, R. A., Gibson, T. M., Brockie, H. C., Leslie, M., Pashmi, G., Craib, S. J., Di Marzo, V., & Pertwee, R. G. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703850 · Cited by 237 · cited 6×
“, 2004), or the allosteric action of PEA as capsazepine has been shown to compete for the binding site for anandamide (De Petrocellis et al., 2001a; Ross et al., 2001) and show modality-dependent antagonist activity at TRPV1 receptors (Savidge et al.”
BackgroundMethodInfluentialDi Marzo, V., Bisogno, T., & De Petrocellis, L. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01712-0 · Cited by 225
Cloning and Pharmacological Characterization of the Rat CB2 Cannabinoid Receptor
Griffin, G., Tao, Q., & Abood, M. E. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35367-4 · Cited by 207
A novel probe for the cannabinoid receptor
Devane, W. A., Breuer, A., Sheskin, T., Jaerbe, T. U. C., Eisen, M. S., & Mechoulam, R. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00089a018 · Cited by 205
Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors
De Petrocellis, L., Davis, J. B., & Di Marzo, V. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02934-9 · Cited by 204
De Petrocellis, L., Harrison, S., Bisogno, T., Tognetto, M., Brandi, I., Smith, G. D., Creminon, C., Davis, J. B., Geppetti, P., & Di Marzo, V. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00406.x · Cited by 200
Re, G., Barbero, R., Miolo, A., & Di Marzo, V. (2007) · The Veterinary Journal · doi:10.1016/j.tvjl.2005.10.003 · Cited by 199 · cited 2×
“known to act as an anti-inflammatory and antinociceptive agent (Re et al., 2007), whereas recent studies indicate that OEA regulates feeding and body weight (Lo Verme et al.”
ResultMaurelli, S., Bisogno, T., De Petrocellis, L., Di Luccia, A., Marino, G., & Di Marzo, V. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01311-3 · Cited by 199
Effects of anandamide on cannabinoid receptors in rat brain membranes
Childers, S. R., Sexton, T., & Roy, M. B. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90134-1 · Cited by 176
Regulation of food intake by oleoylethanolamide
Lo Verme, J., Gaetani, S., Fu, J., Oveisi, F., Burton, K., & Piomelli, D. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4494-0 · Cited by 169
Richardson, D., Ortori, C. A., Chapman, V., Kendall, D. A., & Barrett, D. A. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2006.10.039 · Cited by 169
Self-citationO’Sullivan, S. E., Tarling, E. J., Bennett, A. J., Kendall, D. A., & Randall, M. D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.121 · Cited by 159
Self-citationThe complexities of the cardiovascular actions of cannabinoids
Randall, M. D., Kendall, D. A., & O'Sullivan, S. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705725 · Cited by 159
Self-citationJonsson, K., Vandevoorde, S., Lambert, D. M., Tiger, G., & Fowler, C. J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704199 · Cited by 158
N-acylethanolamine accumulation in infarcted myocardium
Epps, D. E. V., Schmid, P. C., Natarajan, V., & Schmid, H. H. O. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)91281-6 · Cited by 145
Smart, D., Jonsson, K., Vandevoorde, S., Lambert, D. M., & Fowler, C. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704732 · Cited by 140
Farquhar-Smith, P. W., Jaggar, S., & Rice, A. S. C. (2002) · Pain · doi:10.1016/s0304-3959(01)00419-5 · Cited by 133
Mechanisms of anandamide‐induced vasorelaxation in rat isolated coronary arteries
White, R., Ho, W. ‐. V., Bottrill, F. E., Ford, W. R., & Hiley, C. R. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704333 · Cited by 115
Self-citationLambert, D. M., DiPaolo, F. G., Sonveaux, P., Kanyonyo, M. R., Govaerts, S. J., Hermans, E., Bueb, J., Delzenne, N. M., & Tschirhart, E. J. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00132-8 · Cited by 113
Role and regulation of acylethanolamides in energy balance: focus on adipocytes and β‐cells
Matias, I., Gonthier, M., Petrosino, S., Docimo, L., Capasso, R., Hoareau, L., Monteleone, P., Roche, R., Izzo, A. A., & Marzo, V. D. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707424 · Cited by 110
Kondo, S., Sugiura, T., Kodaka, T., Kudo, N., Waku, K., & Tokumura, A. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0688 · Cited by 92
Pacher, P., Bátkai, S., Osei‐Hyiaman, D., Offertáler, L., Liu, J., Harvey-White, J., Brassai, A., Járai, Z., Cravatt, B. F., & Kunos, G. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00107.2005 · Cited by 79
Ho, W. ‐. V., & Randall, M. D. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707141 · Cited by 72
Self-citationRusso, R., LoVerme, J., Rana, G. L., D’Agostino, G., Sasso, O., Calignano, A., & Piomelli, D. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.03.007 · Cited by 55
Ho, W. ‐. V., & Hiley, C. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705280 · Cited by 49
Self-citationVR1-Mediated Depressor Effects During High-Salt Intake: Role of Anandamide
Wang, Y., Kaminski, N. E., & Wang, D. H. (2005) · Hypertension · doi:10.1161/01.hyp.0000174596.95607.fd · Cited by 47
Savidge, J. R., Ranasinghe, S., & Rang, H. P. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00447-4 · Cited by 45
Movahed, P., Evilevitch, V., Andersson, T. L. G., Jönsson, B., Wollmer, P., Zygmunt, P. M., & Högestätt, E. D. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706313 · Cited by 44
Rademacher, D. J., Patel, S., Ho, W. ‐. V., Savoie, A. M., Rusch, N. J., Gauthier, K. M., & Hillard, C. J. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00978.2004 · Cited by 22
Self-citationVandevoorde, S., Lambert, D. M., Smart, D., Jonsson, K., & Fowler, C. J. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00567-9 · Cited by 13
Cited by
Saturnino, C., Popolo, A., Ramunno, A., Adesso, S., Pecoraro, M., Plutino, M., Rizzato, S., Albinati, A., Marzocco, S., Sala, M., et al. (2017) · Molecules · doi:10.3390/molecules22040616 · Cited by 449
Iannotti, F. A., Di Marzo, V., & Petrosino, S. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.02.002 · Cited by 357
Petrosino, S., & Di Marzo, V. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13580 · Cited by 328
Threatened by mining, polymetallic nodules are required to preserve abyssal epifauna
Vanreusel, A., Hilario, A., Ribeiro, P. A., Menot, L., & Arbizu, P. M. (2016) · Scientific Reports · doi:10.1038/srep26808 · Cited by 302
Incorporation of therapeutically modified bacteria into gut microbiota inhibits obesity
Chen, Z., Guo, L., Zhang, Y., L. Walzem, R., Pendergast, J. S., Printz, R. L., Morris, L. C., Matafonova, E., Stien, X., Kang, L., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72517 · Cited by 277
Metadata
- Authors
- Ho, W., Barrett, D. A., & Randall, M. D.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2008-11
- Volume
- 155
- Issue
- 6
- Pages
- 837-846
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2104980609
- Cited by
- 259
- References
- 55
- FWCI
- 5.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.